Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report)’s stock price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.88 and traded as high as $1.84. Mesoblast shares last traded at $1.84, with a volume of 5,246 shares trading hands.
Mesoblast Stock Up 6.4 %
The stock has a 50 day simple moving average of $1.15 and a two-hundred day simple moving average of $0.88.
Mesoblast Company Profile
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.
Further Reading
- Five stocks we like better than Mesoblast
- About the Markup Calculator
- Top 3 Investment Themes to Watch for in 2025
- What Does Downgrade Mean in Investing?
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- Top Stocks Investing in 5G Technology
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.
